Medical Device Testing Market Size, Share, Trends and Forecast, 2026–2034

Market Overview

The global medical device testing market is expanding as medical device manufacturers increasingly require comprehensive testing to verify product safety, performance, quality, and regulatory compliance. Testing services cover several critical evaluations, including biocompatibility, electrical safety, mechanical performance, sterility, durability, and functionality before medical devices receive approval for commercial use. Continuous innovation in medical technologies, growing manufacturing volumes, and the increasing adoption of connected medical devices are supporting demand for specialized testing and validation services.

Access the detailed report and request a sample: http://straitsresearch.com/report/medical-device-testing-market/request-sample

Market Size and Forecast

The global medical device testing market size was valued at USD 8.52 billion in 2025. The market is projected to increase from USD 8.90 billion in 2026 to USD 12.66 billion by 2034, registering a compound annual growth rate (CAGR) of 4.5% during the forecast period from 2026 to 2034. North America dominated the market in 2025, accounting for 38.4% of global revenue.

The market outlook reflects increasing requirements for product verification, quality assurance, and regulatory compliance throughout medical device development and manufacturing. Growing demand for specialized testing capabilities, particularly for connected devices and advanced diagnostic technologies, is also contributing to market expansion.

Market Drivers

Medical Device Innovation Increases Testing Requirements

Continuous innovation in medical devices is increasing the need for comprehensive testing to verify product safety, accuracy, and performance before market entry. Advanced technologies and increasingly complex device designs require detailed evaluations to identify technical issues and ensure reliable operation. For instance, wearable glucose monitors and advanced diagnostic devices undergo performance and reliability testing before commercial use. These requirements are increasing demand for specialized testing services and advanced laboratory capabilities.

Growing Medical Device Manufacturing Boosts Market Demand

Increasing medical device manufacturing is expanding the volume of products requiring quality checks and validation during production. Manufacturers depend on testing services to identify defects, verify material quality, and maintain consistent product performance across production batches. Surgical instruments and infusion pumps, for example, undergo mechanical, electrical, and functional testing before product release. Higher manufacturing output supports recurring demand for testing services and creates opportunities for testing laboratories.

Market Challenges

Complex Testing Requirements for Advanced Devices

The increasing complexity of medical devices requires more comprehensive testing across multiple performance and safety parameters. Connected devices, active medical technologies, implants, and advanced diagnostic products require specialized evaluations to verify their functionality and reliability. Manufacturers must address different testing requirements throughout product development and validation, increasing the importance of technical expertise and advanced laboratory capabilities.

Regulatory Compliance Requirements

Medical device manufacturers must demonstrate product safety, quality, and performance through appropriate testing and verification procedures. Evolving regulatory requirements across markets increase the need for specialized compliance assessments and quality-system evaluations. These requirements can make testing processes more demanding, particularly for manufacturers developing connected devices and technologies intended for multiple international markets.

Market Opportunities

Growing Demand for Cybersecurity Testing

Increasing adoption of connected medical devices is creating opportunities for specialized cybersecurity testing services. Network-connected monitors, infusion systems, and wearable devices require assessments of software vulnerabilities, data protection, and communication security. Demand for penetration testing, software security validation, and connected-device risk assessments is supporting the growth of cybersecurity testing, which is projected to register the highest CAGR of 8.43% from 2026 to 2034.

Expansion of Outsourced Testing Services

The growing need for specialized testing expertise and advanced laboratory infrastructure is creating opportunities for outsourced service providers. Manufacturers can access external technical capabilities and testing facilities to support regulatory compliance, product validation, and quality assurance. The outsourced segment is expected to grow at a CAGR of 6.89% during the forecast period, reflecting increasing demand for specialized testing support and cost efficiency.

Market Segmentation

The medical device testing market is segmented by service type, testing type, phase, sourcing type, and technology.

By Service Type

Testing services dominated the market, accounting for 61.5% of the market share in 2025. This leadership is supported by stringent regulatory requirements, increasing demand for product safety and performance validation, and the growing complexity of medical devices. Testing services are also projected to record the highest CAGR of 6.52% during the forecast period, driven by medical device innovation and expanding compliance requirements.

By Testing Type

Physical testing held the largest market share of 34.6% in 2025, supported by the need to assess device durability, mechanical performance, reliability, and compliance with safety standards. Cybersecurity testing is projected to be the fastest-growing segment, registering a CAGR of 8.43% from 2026 to 2034. Increasing device connectivity and the need to protect patient data are supporting this growth.

By Phase

The preclinical segment accounted for the largest market share of 57.9% in 2025. The segment is projected to grow at a CAGR of 6.18%, supported by the need to evaluate device safety, functionality, and performance before clinical evaluation and regulatory submission. The clinical segment is expected to register a CAGR of 6.34%, driven by increasing clinical investigations and the development of innovative medical technologies.

By Sourcing Type

The in-house segment is projected to grow at a CAGR of 5.41%, supported by manufacturers' preference for greater control over testing procedures, confidential product information, and internal quality management. The outsourced segment is expected to record a higher CAGR of 6.89%, driven by demand for specialized expertise, advanced laboratory infrastructure, cost efficiency, and regulatory support.

By Technology

Non-active medical devices held the largest market share of 22.8% in 2025. Their extensive use and the need for safety, material quality, and performance validation support this position. In-vitro diagnostic medical devices are projected to register the highest CAGR of 7.16%, supported by growing demand for advanced diagnostic technologies, rapid and molecular testing, and accurate diagnostic results.

Regional Analysis

North America

North America dominated the medical device testing market, accounting for 38.4% of global revenue in 2025. The U.S. market is supported by quality and compliance requirements, including the FDA's Quality Management System Regulation, effective February 2, 2026, which incorporates ISO 13485:2016 into its regulatory framework. Updated FDA cybersecurity guidance issued in February 2026 also reinforces testing requirements for connected medical devices.

In Canada, evolving medical device reporting and establishment licensing requirements are strengthening regulatory oversight. These developments support the need for testing, quality assurance, and compliance services.

Asia-Pacific

Asia-Pacific is projected to be the fastest-growing regional market, registering a CAGR of 7.84% from 2026 to 2034. In Japan, initiatives supporting medical device innovation, AI-enabled technologies, clinical evidence development, and international market access are creating demand for product validation and regulatory testing.

China's plans to strengthen medical device lifecycle supervision, national standards, and oversight of emerging technologies are supporting the need for testing capabilities. In India, government initiatives such as the Medical Device Parks Scheme and the Scheme for Strengthening of Medical Device Industry are supporting testing infrastructure and manufacturing capabilities.

Europe

Europe accounted for 27.6% of the medical device testing market in 2025. In the U.K., regulatory modernisation and plans to strengthen lifecycle safety monitoring, device traceability, and oversight of AI-enabled medical devices are supporting demand for verification and compliance testing.

Germany's expanding in-vitro diagnostic market and broader medical technology industry are also creating demand for device performance, safety, and regulatory-compliance testing.

Key Players

The medical device testing market is moderately fragmented, with established testing, inspection, and certification companies competing alongside specialized laboratories, contract research organizations, and independent testing providers. The leading companies include:

1. SGS SA (Switzerland)

2. Eurofins Scientific SE (Luxembourg)

3. Bureau Veritas SA (France)

4. Intertek Group plc (United Kingdom)

5. Element Materials Technology (United Kingdom)

6. Envigo (United Kingdom)

7. Avomeen Analytical Services (U.S.)

8. Gateway Analytical, LLC (U.S.)

These companies compete through testing accuracy, regulatory expertise, laboratory accreditation, technical capabilities, service portfolios, global laboratory networks, and turnaround times. Specialized capabilities in biocompatibility, software validation, cybersecurity, and connected medical devices are also important competitive factors.

Recent industry developments include Eurofins Scientific's laboratory infrastructure upgrades in April 2026, UL Solutions' expanded cybersecurity and safety testing services in February 2026, and testing and certification capability expansions by TÜV SÜD in October 2025 and Intertek in June 2025.

Conclusion

The medical device testing market is expected to experience steady growth through 2034, supported by medical device innovation, expanding manufacturing activities, and increasing requirements for product safety and regulatory compliance. North America currently leads the market, while Asia-Pacific is projected to record the fastest growth. Cybersecurity testing, outsourced testing services, and in-vitro diagnostic medical devices represent important growth areas during the forecast period.

The global medical device testing market is projected to reach USD 12.66 billion by 2034, growing at a CAGR of 4.5% from 2026 to 2034.

Read the full report: http://straitsresearch.com/report/medical-device-testing-market